140 related articles for article (PubMed ID: 20882990)
21. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
[TBL] [Abstract][Full Text] [Related]
22. Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration.
Sewell JM; Smyth JF; Langdon SP
Exp Cell Res; 2005 Mar; 304(1):305-16. PubMed ID: 15707595
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
Liu C; Tsao MS
Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
26. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
Srivastava A; Alexander J; Lomakin I; Dayal Y
Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
[TBL] [Abstract][Full Text] [Related]
28. EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL.
Stoll SW; Benedict M; Mitra R; Hiniker A; Elder JT; Nuñez G
Oncogene; 1998 Mar; 16(11):1493-9. PubMed ID: 9580112
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
30. A reference map of human nasopharyngeal squamous carcinoma proteome.
Li F; Xiao Z; Zhang P; Li J; Li M; Feng X; Guan Y; Chen Z
Int J Oncol; 2007 May; 30(5):1077-88. PubMed ID: 17390009
[TBL] [Abstract][Full Text] [Related]
31. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
32. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors.
Sun Y; Fry DW; Vincent P; Nelson JM; Elliott W; Leopold WR
Anticancer Res; 1999; 19(2A):919-24. PubMed ID: 10368634
[TBL] [Abstract][Full Text] [Related]
34. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
35. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
El-Obeid A; Hesselager G; Westermark B; Nistér M
Biochem Biophys Res Commun; 2002 Jan; 290(1):349-58. PubMed ID: 11779176
[TBL] [Abstract][Full Text] [Related]
36. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
Zhao X; Ramsey KE; Stephan DA; Russell P
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
[TBL] [Abstract][Full Text] [Related]
37. Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.
Ruan L; Wang GL; Chen Y; Yi H; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
Med Oncol; 2010 Dec; 27(4):1407-14. PubMed ID: 20049563
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells.
Sung FL; Poon TC; Hui EP; Ma BB; Liong E; To KF; Huang DP; Chan AT
In Vivo; 2005; 19(1):237-45. PubMed ID: 15796181
[TBL] [Abstract][Full Text] [Related]
39. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells.
Wang L; Ma J; Li J; Li X; Zhang Q; Peng S; Peng C; Zhou M; Xiong W; Yang J; Zhou J; Fan S; Tan C; Yan Q; Shen S; Li G
J Cell Biochem; 2005 May; 95(1):64-73. PubMed ID: 15723283
[TBL] [Abstract][Full Text] [Related]
40. Identification of nm23-H1 as a metastatic suppressor and prognostic factor in nasopharyngeal carcinoma by proteomic analysis.
Li X; Hu R; Qu J; He Q; Chen Y; Li J; Ye X; Xiang Y; Yi H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):17-26. PubMed ID: 22349375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
